Starpharma has struck a deal to develop cancer therapies which could be worth hundreds of millions of dollars. The post See ...

For our methodology, we first screened biotech stocks trading below $5 per share and showing positive year-to-date (YTD) ...

Radiance Technologies has been awarded a prime Other Transaction (OT) contract valued up to $5.85 million over 18 months by the Defense Advanced Research Projects Agency (DARPA) ...

Athos Therapeutics launches a new AI platform, Athos Omics AI, to provide no-code, micro-analytics for drug, food, and ...

Thinking about a career change or a step up in the biotech world? It’s a field that’s really growing, and getting some extra training can make a big difference. Many professionals find that a ...

If you want one reason to buy Solana right now, this is it: There are customers consistently paying to use the applications on its chain, and far more of them than on any other network. But why does ...

MLYS, SNDX, and TVTX are three promising biotech stocks that are poised for growth or potential buyouts. Here's what ...

For many private biotech companies, a successful initial public offering (IPO) remains a major aspiration as it can be a crucial catalyst for growth. It’s a move that can deliver vital funding for ...

Olga Berson of Thompson Coburn LLP discusses opportunities as well as intellectual property pitfalls for sovereign wealth ...

A plan to genetically engineer a version of the dodo, a giant flightless bird that disappeared 400 years ago and became the ...

A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new ...

Medcaptain sells its life-support and testing products in more than 140 countries and regions, with strong positions in ...